Technical Description
The invention presents a novel drug delivery system using a biocompatible Cyclodextrin-grafted polyurethane hydrogel.
Problems Addressed
- Chemo Side Effects
- High Normal Cell Toxicity
- High Drug Doses Needed
- Skin Cancer Challenge
- Drug Resistance Issues
- Low Drug Bioavailability
- Adverse Effects on Tissues
- Poor Melanoma Treatment Responses
- Less Target-specific Action
- Challenges in Topical Drug Delivery
- Limited Efficacy
Tech Features
- Bioavailability Enhancement
- Targeted Delivery
- Eco-friendly Hydrogel
- Bio-compatible Hydrogel
- Targeted Drug Release
- Polymer Conjugates
- Cyclodextrin Grafting
- Drug-loaded Hydrogel
Target Audience
- Pharmaceutical Industry
- Cancer Research
- Dermatology Clinics
- Biomedical Research Institutions
- Biotechnology Industry
- Chemical and Polymer Industries
Tech ID: P27-1138 TRL 4 Patent Status: Granted Available For Exclusive and Non-exclusive License
